Alkermes
Alkermes is a provider of innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies its scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.
Financial Data
-
31st Dec 17 Source: Company
- €541.4 million turnover
-
-€146.6 million
profit - 2,000 employees
-
31st Dec 16 Source: CRO
- €438 million turnover
-
€147.3 million
profit - 380 employees
- 5 more years available »
Ranking
By Turnover
(€541.4 million)- 144th in Top Companies
- 20th in Health
- 18th in Pharma
By Employees
(2,000)- 124th in Top Companies
- 21st in Health
- 11th in Pharma
-
- 2,000
- €541.4 million
Employees
- Richard Pops CEO/Managing Director
Latest News
- Dec 13 Operating profits at INEC owner decrease 7% to €1.32m
- Dec 13 O’Leary told Bellew ‘you are f***ing useless’ in Ryanair meetings, court hears
- Dec 13 Iseq hits 12-year high after UK election result
- Dec 13 Crude oil breaks $65 mark after Opec tightens supplies
- Dec 13 Aston Martin in talks to raise equity capital